Atlas Trials

Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)

Clinical trial NCT03221751 · TERMINATED

Trial details

NCT number
NCT03221751
Sponsor
VA Office of Research and Development
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Dementia
Start date
2016-12-01
Primary completion
2023-01-03
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.